Epigenetic silencing of EVL/miR-342 in multiple myeloma
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Translational Research
- Vol. 192, 46-53
Abstract
No abstract availableKeywords
Funding Information
- Hong Kong Blood Cancer Foundation
- NSFC (81470369)
This publication has 40 references indexed in Scilit:
- Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia - implications on constitutive activation of NFκB pathwayMolecular Cancer, 2013
- Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLALCancer Cell International, 2013
- Epigenetic inactivation of the MIR129-2 in hematological malignanciesJournal of Hematology & Oncology, 2013
- Epigenetic Inactivation of the miR-124-1 in Haematological MalignanciesPLOS ONE, 2011
- Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myelomaBlood, 2011
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyBlood, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myelomaBMC Medical Genomics, 2008
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998